Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:31 PM
Ignite Modification Date:
2025-12-24 @ 2:31 PM
NCT ID:
NCT00246259
Eligibility Criteria:
Inclusion Criteria:
* In-patients or out-patients
* Primary Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV) diagnosis of schizophrenia, schizophreniform disorder or schizoaffective disorder for no longer than 3 years after diagnosis and treatment of a psychotic illness
* Positive and Negative Syndrome Scale (PANSS) score of 60-120 at Visit 1 and 2
* Currently on monotherapy atypical antipsychotic treatment below local label guidelines or treatment naive
* Able to complete self-assessments in either English or French
Exclusion Criteria:
* Current primary Axis-1 diagnosis other than schizophrenia, schizophreniform disorder or schizoaffective disorder, according to DSM-IV
* Current drug or alcohol dependence
* Treatment with a depot antipsychotic within 3 months of study start
* Confirmed or suspected history of lack of tolerability, hypersensitivity or allergy to risperidone
* Risperidone non-responders (based on evidence of adequate trial of treatment)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
30 Years
Study:
NCT00246259
Study Brief:
Protocol Section:
NCT00246259